You are here

• Home
• Therapy Areas
• Neuroscience

• An Open-Label, Multi-Center, Phase I Study To Compare the Pharmacokinetics of a Single Oral Dose of TC-5214 (S-Mecamylamine) in Subjects With Renal Impairment With Subjects With Normal Renal Function

Disease

renal impairment

Drug Name

TC-5214

Generic Name

TC-5214

Sponsor

AstraZeneca

Drug Status

Discontinued

Phase

I

Start Date

Nov 12, 2010

Study Name

D4130C00008

Study Id

D4130C00008

ClinicalTrials.gov ID

NCT01240967

Recruiting Status

Closed

Protocol Status

Not Available

Report

Dec 20, 2011

• D4130C00008.pdf (150 KB)

Page tools

• Print
• Bookmark this page